Genetic advances in glioma: susceptibility genes and networks

Curr Opin Genet Dev. 2010 Jun;20(3):239-44. doi: 10.1016/j.gde.2010.02.001. Epub 2010 Mar 6.

Abstract

Recent advances in human genome studies have opened new avenues for the identification of susceptibility genes for many complex genetic disorders, especially in the field of rare cancers such as glioma. To date, eight glioma susceptibility loci have been identified by candidate gene-association studies: PRKDC G6721T, XRCC1 W399R, PARP1 A762V, MGMT F84L, ERCC1 A8092C, ERCC2 Q751K, EGF +61 A/G, and IL13 R110G. Five loci have been identified by genome-wide association studies: TERT rs2736100, CCDC26 rs4295627, CDKN2A-CDKN2B rs4977756, PHLDB1 rs498872, and RTEL1 rs6010620. Using the Ingenuity Pathway Analysis tool, we investigated whether these 13 susceptibility genes are biologically related. Our data provide not only networks for understanding the biological properties of gliomagenesis but also useful pathway maps for future understanding of disease.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Gene Regulatory Networks*
  • Genetic Predisposition to Disease / genetics*
  • Genome-Wide Association Study / methods*
  • Glioma / genetics*
  • Humans
  • Polymorphism, Single Nucleotide